drugset / Trial / NCT05567523

Safety Study of Dexmedetomidine in Elderly Under General Anesthesia

NCT05567523 ↗

Phase 4 Completed 200 enrolled Zhenjiang First People's Hospital
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to find out appropriate dose range of dexmedetomidine to provide the elderly patients satisfactory sedation and analgesia with stable hemodynamics during perioperative period of hip replacement under general anesthesia.

Timeline

Start
2019-06-01
Primary completion
2022-02-28
Completion
2022-03-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —
Comparator Midazolam Small molecule 0.03 mg/kg —

Indications

No indication recorded.